“Repurposing Mitragynine as Anti-SARS-CoV-2 Agent Evidenced by In Silico Predictive Approach”, Mal. J. Fund. Appl. Sci., vol. 18, no. 6, pp. 644–653, Dec. 2022, doi: 10.11113/mjfas.v18n6.2637.